Mikhail Kalinichev
HEAD OF TRANSLATIONAL SCIENCE · Addex Therapeutics Ltd.
Individual
- 2026
- Sep 4, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Mikhail Kalinichev's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
- Framework Ventures IV L.P. - $42.62M in SDEV purchases and sales in the last 12 months
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
- Jesse J. Geiger - $41.11M in MEDP purchases and sales in the last 12 months
- Mark Hancock - $40.97M in PACS purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mikhail Kalinichev?
Mikhail Kalinichev is a corporate insider, tracked as HEAD OF TRANSLATIONAL SCIENCE of Addex Therapeutics Ltd. (ADXN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mikhail Kalinichev submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
